Is immunosuppression status a risk factor for noninvasive ventilation failure in patients with acute hypoxemic respiratory failure? A post hoc matched analysis

BACKGROUND: Recent European/American guidelines recommend noninvasive ventilation (NIV) as a first-line therapy to manage acute hypoxemic respiratory failure in immunocompromised patients. By contrast, NIV may have deleterious effects in nonimmunocompromised patients and experts have been unable to...

Descripción completa

Detalles Bibliográficos
Autores principales: Coudroy, Rémi, Pham, Tài, Boissier, Florence, Robert, René, Frat, Jean-Pierre, Thille, Arnaud W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6692798/
https://www.ncbi.nlm.nih.gov/pubmed/31414246
http://dx.doi.org/10.1186/s13613-019-0566-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6692798/
https://www.ncbi.nlm.nih.gov/pubmed/31414246
http://dx.doi.org/10.1186/s13613-019-0566-z

Ejemplares similares